Scholars Central

OpinionPublished 29 Jan 2025

Pathophysiology, Clinical Impact, and Emerging Therapeutic Strategies of Metabolic Dysfunction

Authors: Joseph Mugisha

Journal of Diabetes & Metabolism

Volume 16 · Issue 1 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metabolic dysfunction is a complex condition characterized by disruptions in fundamental biochemical pathways that regulate energy homeostasis, glucose metabolism, and lipid balance. It is a hallmark of several metabolic disorders, including obesity, Type 2 Diabetes Mellitus (T2DM), and metabolic syndrome. These dysfunctions arise due to a combination of genetic predisposition, lifestyle factors, and environmental influences. Insulin resistance, chronic inflammation, and mitochondrial abnormalities are key contributors to metabolic impairment. The clinical implications of metabolic dysfunction are extensive, leading to an increased risk of cardiovascular diseases, neurodegenerative disorders, and Non-Alcoholic Fatty Liver Disease (NAFLD). Understanding the underlying mechanisms is crucial for developing effective therapeutic strategies, ranging from pharmacological interventions to lifestyle modifications. This review explores the pathophysiological aspects of metabolic dysfunction, its clinical impact, and current advances in treatment approaches.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Diabetes & Metabolism
  • SubjectDiabetes & Endocrinology
  • BylineArticles whose byline prints “Joseph Mugisha”